Biopsy or biomarkers: Is there a gold standard for diagnosis of liver fibrosis?

被引：51

作者：

Afdhal, NH ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Liver Ctr, Boston, MA 02125 USA

来源：

CLINICAL CHEMISTRY | 2004年 / 50卷 / 08期

关键词：

D O I：

10.1373/clinchem.2004.035899

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1299 / 1300

页数：2

共 8 条

[1] Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?
Afdhal, NH
[J]. HEPATOLOGY, 2003, 37 (05) : 972 - 974
[2] AFDHAL NH, 2004, IN PRESS AM J GASTRO
[3] Sampling variability of liver fibrosis in chronic hepatitis C
Bedossa, P
Dargère, D
Paradis, V
[J]. HEPATOLOGY, 2003, 38 (06) : 1449 - 1457
[4] Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
Imbert-Bismut, F
Messous, D
Thibaut, V
Myers, RB
Piton, A
Thabut, D
Devers, L
Hainque, B
Mercadier, A
Poynard, T
[J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (03) : 323 - 333
[5] Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
Imbert-Bismut, F
Ratziu, V
Pieroni, L
Charlotte, F
Benhamou, Y
Poynard, T
[J]. LANCET, 2001, 357 (9262) : 1069 - 1075
[6] Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C
Poynard, T
Munteanu, M
Imbert-Bismut, F
Charlotte, F
Thabut, D
Le Calvez, S
Messous, D
Thibault, V
Benhamou, Y
Moussalli, J
Ratziu, V
[J]. CLINICAL CHEMISTRY, 2004, 50 (08) : 1344 - 1355
[7] Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin
Poynard, T
McHutchison, J
Manns, M
Myers, RP
Albrecht, J
[J]. HEPATOLOGY, 2003, 38 (02) : 481 - 492
[8] Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x

← 1 →